A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
Clinical trial NCT02215616 · COMPLETED
Trial details
- NCT number
- NCT02215616
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2018-06-19
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.